secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIORA THERAPEUTICS, INC. (—)
CIK:        0001580063
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001193125-23-296812
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biora Therapeutics receives Nasdaq notice of non-compliance with MVLS minimum $50M requirement
--------------------------------------------------------------------------------

- Received Nasdaq notification on Dec 11, 2023 that MVLS was below $50M for 30 consecutive business days.
- Company has 180 calendar days, until June 10, 2024, to regain compliance.
- To regain compliance, MVLS must equal or exceed $50M for at least ten consecutive business days.
- If not compliant by deadline, Nasdaq will initiate delisting; company may appeal or transfer to Nasdaq Capital Market.
- No immediate effect on listing or trading of common stock on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580063/000119312523296812/0001193125-23-296812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580063/000119312523296812/d77822d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer